Citrullinated amyloid-β (1-42) peptide (human) contains citrulline-modified residues that alter charge distribution and folding dynamics. These changes influence aggregation behavior and molecular interactions. The sequence is used to study structural consequences of post-translational modification. Researchers examine it to map peptide–protein interaction patterns.
CAT No: A13396
Synonyms/Alias:Citrullinated Aβ (1-42); Citrullinated Aβ42; R5C1-42
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More